Becton Dickinson (BDX) Free Cash Flow Growth (1y) (2010 - 2026)
Becton Dickinson (BDX) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 73.89% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 271.70% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -45.89% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -6.70% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 9.81% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 432.60% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 339.10% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 124.13% |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 105.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 271.70% |
| Dec 31, 2025 | -6.63% |
| Sep 30, 2025 | 13.61% |
| Jun 30, 2025 | 25.04% |
| Mar 31, 2025 | -183.68% |
| Dec 31, 2024 | -20.43% |
| Sep 30, 2024 | -14.45% |
| Jun 30, 2024 | 25.62% |
| Mar 31, 2024 | 9,400.00% |
| Dec 31, 2023 | 286.91% |
| Sep 30, 2023 | 56.69% |
| Jun 30, 2023 | 109.41% |
| Mar 31, 2023 | -94.12% |
| Dec 31, 2022 | -44.96% |
| Sep 30, 2022 | 69.15% |
| Jun 30, 2022 | 32.40% |
| Mar 31, 2022 | -92.73% |
| Dec 31, 2021 | -73.04% |
| Sep 30, 2021 | -44.98% |
| Jun 30, 2021 | -51.36% |